Thoughts on solution for gw-501516

  1. New Member
    serrow's Avatar
    Stats
    5'3"  155 lbs.
    Join Date
    Dec 2012
    Posts
    5
    Rep Power
    26
    Level
    2
    Lv. Percent
    51.5%

    Thoughts on solution for gw-501516


    I have a good amount of gw-501516 arriving soon in powder form. Any thoughts on making a solution?

  2. Banned
    AwhYeah's Avatar
    Stats
    5'11"  192 lbs.
    Join Date
    Jun 2012
    Age
    24
    Posts
    295
    Rep Power
    0
    Level
    15
    Lv. Percent
    28.44%

    Was interested in GW till this:


    Can anyone decipher this?

    GW-501516 and COX-2 -- A Warning



    To everyone on the board interested in this new research chemical:

    You may have seen the study indicating an increase in the size and quantity of intestinal adenomas in Apcmin mice (predisposed to intestinal polyposis).

    Because GW-501516 works primarily and tangentially by up-regulating gene expression, I was curious to see if it had any effects on genes responsible for carcinogenesis.

    Turns out it does. The COX-2 gene is primarily responsible for pain and inflammation in the body, but interestingly, increased mRNA expression of this gene alters the apoptotic mechanisms of certain cells. All cells have mechanisms to "self-destruct" when their DNA becomes damaged beyond repair, but by altering the Bcl-2 protein and p53 pathway, up-regulation of COX-2 reduces the apoptotic response.

    COX-2 expression has already been shown to have a significant positive correlation with both carcinogenesis and tumorigenesis, and GW-501516 has also been proven to increase COX-2 expression.

    Therefore, to anyone [who's rats are] taking this compound, you should ALWAYS co-supplement with a COX-2 inhibitor. There are various NSAIDs on the market which show an affinity for COX-2 inhibition (vs COX-1) such as Celecoxib (Celebrex), however these have also been linked in rare cases to renal failure, stroke, thrombosis, etc. Your best bet is Tribulus Terrestris, which is a natural extract, and has been shown to inhibit COX-2 expression by as much as 80%


    Activation of nuclear hormone receptor peroxisome proliferator-activated receptor-delta accelerates intestinal adenoma growth.
    Gupta RA, Wang D, Katkuri S, Wang H, Dey SK, DuBois RN.
    Source
    Department of Medicine, The Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-6838, USA.
    Abstract
    We treated Apc(min) mice, which are predisposed to intestinal polyposis, with a selective synthetic agonist of peroxisome proliferator-activated receptor-delta (PPAR-delta). Exposure of Apc(min) mice to the PPAR-delta ligand GW501516 resulted in a significant increase in the number and size of intestinal polyps. The most prominent effect was on polyp size; mice treated with the PPAR-delta activator had a fivefold increase in the number of polyps larger than 2 mm. Our results implicate PPAR-delta in the regulation of intestinal adenoma growth.

    PPARdelta activation induces COX-2 gene expression and cell proliferation in human hepatocellular carcinoma cells.
    Glinghammar B, Skogsberg J, Hamsten A, Ehrenborg E.
    Source
    King Gustaf V Research Institute, Karolinska Institutet, Karolinska Hospital, S-171 76 Stockholm, Sweden.
    Abstract
    Cyclooxygenase-2 (COX-2) has been suggested to be associated with carcinogenesis. Recently, many studies have shown increased expression of COX-2 in a variety of human malignancies, including hepatocellular carcinoma (HCC). Therefore, it becomes important to know more about what determines COX-2 expression. In this work, we have studied the effect of PPARdelta activation on COX-2 expression using a selective agonist (GW501516) in human hepatocellular carcinoma (HepG2) cells. Activation of PPARdelta resulted in increased COX-2 mRNA and protein expression. The mechanism behind the induction seems to be increased activity of the proximal promoter of the COX-2 gene, spanning nucleotides -327 to +59. The increased COX-2 protein expression and promoter activity induced by the GW501516 was also confirmed in the monocytic cell line THP-1. Induced levels of COX-2 have previously been associated with resistance to apoptosis and increased cell proliferation in many cell types. In HepG2 cells, we observed a dose-dependent increase in cell number by GW501516 treatment for 72h. The levels of PCNA, used as an indicator of cell division were induced, and the cell survival promoting complex p65 (NF-kappaB) was phosphorylated under GW501516 treatment. We conclude that PPARdelta activation in HepG2 cells results in induced COX-2 expression and increased cellular proliferation. These results may suggest that PPARdelta plays an important role in the development of HCC by modulating expression of COX-2.

    Evaluation of natural products on inhibition of inducible cyclooxygenase (COX-2) and nitric oxide synthase (iNOS) in cultured mouse macrophage cells.
    Hong CH, Hur SK, Oh OJ, Kim SS, Nam KA, Lee SK.
    Source
    Department of Pharmacy, College of Pharmacy, Ewha Womans University, 11-1 Daehyun-dong, Seodaemun-ku, 120-750, Seoul, South Korea.
    Abstract
    The inhibitors of prostaglandin biosynthesis and nitric oxide production have been considered as potential anti-inflammatory and cancer chemopreventive agents. In this study, we evaluated approximately 170 methanol extracts of natural products including Korean herbal medicines for the inhibition of prostaglandin E(2) production (for COX-2 inhibitors) and nitric oxide formation (for iNOS inhibitors) in lipopolysaccharide (LPS)-induced mouse macrophages RAW264.7 cells. As a result, several extracts such as Aristolochia debilis, Cinnamomum cassia, Cinnamomum loureirii, Curcuma zedoaria, Eugenia caryophyllata, Pterocarpus santalius, Rehmania glutinosa and Tribulus terrestris showed potent inhibition of COX-2 activity (>80% inhibition at the test concentration of 10 micro g/ml). In addition, the extracts of A. debilis, Caesalpinia sappan, Curcuma longa, C. zedoaria, Daphne genkwa and Morus alba were also considered as potential inhibitors of iNOS activity (>70% inhibition at the test concentration of 10 micro g/ml). These active extracts mediating COX-2 and iNOS inhibitory activities are warranted for further elucidation of active principles for development of new cancer chemopreventive and/or anti-inflammatory agents.
  3. Banned
    AwhYeah's Avatar
    Stats
    5'11"  192 lbs.
    Join Date
    Jun 2012
    Age
    24
    Posts
    295
    Rep Power
    0
    Level
    15
    Lv. Percent
    28.44%

    "This is looking into what happens when one activates PPARd in the gut. The gut is quite sensitive to PPARd relative to other tissues. The Apcmin mouse model is particularly likely to get a type of gut cancer (called intestinal adenomas). When they activated PPARd in this mouse model, they report an increase in the number of tumours ie that PPARd acts as a promotor of tumour growth. Now that said, one cannot extrapolate too much from this study to bodybuilders in general. The evidence of PPARd effects on the gut is quite mixed. Some types of gut inflamatory disorders maybe helped by PPARd, whereas if one has a family history of colon cancer, it maybe wise not to use as there is mixed evidence on the matter (some studies showing no effect, whereas others showing tumour promotion). If you are interested in learning about the effects of PPARd on the gut, checkout [ Peters, Hollingeshead et al, Role of peroxisome-proliferator-activated receptor b/d (PPARb/d) in gastrointestinal tract function and disease, Clinical Science (2008) 115, (107-127) ]. This is a review article which discusses the various evidence in a variety of studies and models, rather than in one particular study. COX2 & iNOS As for blanket recommendations to inhibit COX2 or iNOS, that is very unwise IMHO for bodybuilders. Both COX2 and iNOS play a role in inflammation with two differing effects/systems which are particularly relevant in bodybuilders. COX2 in involved in the inflammation response that occurs when a muscle gets damaged eg( in the gym ). Afterwards there is a change in inflammation where the muscle clears away the debris and rebuilds (how a muscle grows and adapts to work ). There is evidence that COX2 inhibition can interfere with this inhibition, thus interfere with muscle building. Selective COX2 inhibitors do exist as mentioned in the article, but whether or not these have any use (or for that matter relevance) here is another question. The effects mediated through COX2 in the gut may not even be relevant for effects in the muscle, and even if they are, suppressing Arachidonic acid conversion in skeletal muscle may not be ideal for bodybuilders. iNOS is inducible Nitric Oxide Synthase which the body uses as part of it's immune system to kill off certain attackers. Blanket suppression of this system could result in disarming the "police" (called macrophages) of your immune system."
    •   
       

Similar Forum Threads

  1. thoughts on this for PCT
    By lou38 in forum Supplements
    Replies: 9
    Last Post: 02-04-2009, 06:36 PM
  2. Thoughts on supplements for the heart?
    By Dr Liftalot in forum Supplements
    Replies: 5
    Last Post: 09-04-2006, 04:38 PM
  3. Replies: 14
    Last Post: 08-08-2006, 12:45 PM
  4. Thoughts on thios stack for low test levels
    By Maverick64 in forum Supplements
    Replies: 4
    Last Post: 04-23-2006, 03:41 AM

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts
  •  
Log in